Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 16.41 M20.13 M20.23 M17.59 M 74.35 M Research & development 165 K——-82 K — Operating income -20.97 M-21 M-20.66 M-19.35 M -81.98 M Non-Operating Income, Total 44 K40 K4 000-2.78 M -2.69 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 44 K40 K4 000-2.78 M -2.69 M Unusual income/expense ———— — Pretax income 6.1 M7.78 M9.12 M17.49 M 40.49 M Equity in earnings ———— — Taxes 1.03 M1.73 M2.01 M3.01 M 7.79 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 5.07 M6.05 M7.11 M14.48 M 32.7 M Discontinued operations 591 K-30 K-35 K93 K 619 K Net income 5.66 M6.02 M7.07 M14.57 M 33.32 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 5.66 M6.02 M7.07 M14.57 M 33.32 M Basic earnings per share (Basic EPS) 0.170.170.20.42 0.96 Diluted earnings per share (Diluted EPS) 0.170.170.20.42 0.96 Average basic shares outstanding 34.7 M34.84 M34.77 M34.74 M — Diluted shares outstanding 34.7 M34.84 M34.77 M34.74 M — EBITDA -169.32 M-207.62 M-180.36 M-159.91 M -717.22 M EBIT -179.87 M-208.5 M-185.82 M-166.6 M -740.79 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 10.54 M879 K5.46 M6.69 M 23.57 M